13.01.2023 • NewsBASFGeismarpolyurethanes

BASF breaks Ground on Geismar MDI Capacity Upgrade

BASF has broken ground on the third and final phase of its expansion project for polyurethane precursor MDI at its integrated site in Geismar, Louisiana.

The project announced in July 2022 will widen production capacity to around 600,000 t/y by the middle of the decade to support demand growth in North America.

The German chemicals and plastics giant is spending $780 million on the current two phases, lasting from 2022 to 2025, The total investment value comes to around $1 billion, making this BASF’s largest wholly owned investment in North America. 

Through this investment, Michael Heinz, CEO of BASF Corporation, said the Germany-headquartered company is demonstrating its commitment to meeting customers’ needs while strengthening its foundation for continued growth in the important US market.

The implementation of the methylene diphenyl diisocyanate (MDI) capacity...
The implementation of the methylene diphenyl diisocyanate (MDI) capacity increase program for production facilities at BASF’s Verbund site in Geismar, Louisiana, is progressing on schedule. © BASF

Stefan Doerr, senior vice president, Monomers North America, said BASF sees significant growth potential in North American MDI applications, including transportation, automotive, footwear and furniture.

Kicked off in 2018, the expansion project is being implemented in several stages. In a first step, a new MDI synthesis unit went on stream in October 2020, followed in 2021 by the expansion of several existing upstream units.

The third and final phase of the project will add new upstream units and a splitter. Leveraging state-of-the-art technology, the expansion will showcase the highest safety standards combined with advanced digitalization in its operations, BASF said.

Author: Dede Williams, Freelance Journalist

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.